SCHEMBL974964

SCHEMBL974964

CCC(O)CCCCCCCCC(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.74
FFAR1 O14842 3/20 0.74
ALDH1A1 P00352 3/20 0.55
GPR84 Q9NQS5 7/20 0.54
PPARG P37231 7/20 0.54
PPARD Q03181 7/20 0.54
PPARA Q07869 7/20 0.54
HDAC11 Q96DB2 5/20 0.54
TSHR P16473 4/20 0.54
PTPN1 P18031 3/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54
ALOX15 P16050 1/20 0.54
PDE4A P27815 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1879331 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL16230477 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL710625 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL2493087 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL9633164 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1881578 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL16230523 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1877352 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1877955 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1301928 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024060635-A1 POLYHYDROXYALKANOATE COMPOSITION CONTAINING HYDROXY ACID NUCLEATING AGENT, POLYHYDROXYALKANOATE MOLDED BODY, AND PREPARATION METHOD THEREFOR 北京蓝晶微生物科技有限公司 2024-03-28 WO claimed
CN-115232456-B Polyhydroxyalkanoate composition containing hydroxy acid nucleating agent, polyhydroxyalkanoate molded body and preparation method thereof 北京蓝晶微生物科技有限公司 2023-01-17 CN claimed
CN-115232456-A Polyhydroxyalkanoate composition containing hydroxy acid nucleating agent, polyhydroxyalkanoate molded body and preparation method thereof 北京蓝晶微生物科技有限公司 2022-10-25 CN claimed
CN-107653293-A The preparation method of specific site hydroxylating ingane type forskolin 复旦大学 2018-02-02 CN claimed
US-8287764-B2 Coated particles AKZO NOBEL N.V. (NL) 2012-10-16 US claimed
US-20110133128-A1 COATED PARTICLES AKZO NOBEL N.V. (NL) 2011-06-09 US claimed
EP-2303961-A1 COATED PARTICLES Akzo Nobel N.V. (NL) 2011-04-06 EP claimed
WO-2010010052-A1 COATED PARTICLES AKZO NOBEL N.V. (NL) 2010-01-28 WO claimed
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives GENOMATICA, INC. (US) 2026-04-07 US disclosed
US-12427696-B2 Granulation processing method for low-melt-index degradable material, and shaped body prepared thereby SHANGHAI BLUEPHA MICROBIOLOGY TECHNOLOGY CO., LTD. (CN) 2025-09-30 US disclosed
US-12421355-B2 Biodegradable block copolymer TORAY INDUSTRIES, INC. (JP) 2025-09-23 US disclosed
US-20250207159-A1 Microorganisms And Methods For Production Of Fatty Acid Derivatives With Reduced Levels Of Byproducts AGAIN BIO APS (DK) 2025-06-26 US disclosed
CN-113293150-B Mutant enzymes 牛津大学科技创新有限公司 2025-05-13 CN disclosed
EP-4150103-B1 METHOD FOR MANUFACTURING HYDROXY FATTY ACID-BASED POLYOLS U WINDMOELLER INNOVATION GMBH & CO KG (DE) 2025-04-09 EP disclosed
EP-1226189-A1 METAL CONTAINING DISPERSANT POLYMERS FROM CONDENSATION OF POLYMERS CONTAINING ACIDIC GROUP WITH OVERBASED COMPOSITIONS CONTAINING REACTIVE NUCLEOPHILIC GROUP The Lubrizol Corporation (US) 2002-07-31 EP disclosed
US-6403725-B1 OIL ADDITIVES, ANTIDEPOSIT AGENTS THE LUBRIZOL CORPORATION 2002-06-11 US disclosed
US-6350330-B1 EXPLOSIVES, PROPELLANTS ALLIANT TECHSYSTEMS INC. 2002-02-26 US disclosed
WO-2001014433-A1 METAL CONTAINING DISPERSANT POLYMERS FROM CONDENSATION OF POLYMERS CONTAINING ACIDIC GROUP WITH OVERBASED COMPOSITIONS CONTAINING REACTIVE NUCLEOPHILIC GROUP THE LUBRIZOL CORPORATION (US) 2001-03-01 WO disclosed
US-5783601-A CONTAINING HYDROXYCARBOXYLIC ACIDS KAO CORPORATION (JP) 1998-07-21 US disclosed
EP-0808625-A1 External skin-care composition Kao Corporation (JP) 1997-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives CYP4F11, CYP2F1, CYP4Z1 FFAR4 95/4885FFAR1 112/4885ALDH1A1 327/4885
US-20110133128-A1 COATED PARTICLES CD63, CD44, S100A4 FFAR4 4712/4885FFAR1 4823/4885ALDH1A1 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.